AstraZeneca Pharma India plans to sell Bengaluru plant

The company will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as a contract manufacturing organisation (CMO) for its products currently manufactured or packaged at the site, subject to receipt of necessary statutory approvals, the drug firm said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news